170 related articles for article (PubMed ID: 31817839)
1. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE
Garrido MP; Hurtado I; Valenzuela-Valderrama M; Salvatierra R; Hernández A; Vega M; Selman A; Quest AFG; Romero C
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817839
[TBL] [Abstract][Full Text] [Related]
2. Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells.
Garrido MP; Salvatierra R; Valenzuela-Valderrama M; Vallejos C; Bruneau N; Hernández A; Vega M; Selman A; Quest AFG; Romero C
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33081077
[TBL] [Abstract][Full Text] [Related]
3. NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells.
Garrido MP; Torres I; Avila A; Chnaiderman J; Valenzuela-Valderrama M; Aramburo J; Oróstica L; Durán-Jara E; Lobos-Gonzalez L; Romero C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081171
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
[TBL] [Abstract][Full Text] [Related]
5. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells.
Garrido MP; Bruneau N; Vega M; Selman A; Tapia JC; Romero C
Histol Histopathol; 2020 Sep; 35(9):961-971. PubMed ID: 32369181
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
[TBL] [Abstract][Full Text] [Related]
7. Effect of estradiol on the expression of angiogenic factors in epithelial ovarian cancer.
Valladares M; Plaza-Parrochia F; Lépez M; López D; Gabler F; Gayan P; Selman A; Vega M; Romero C
Histol Histopathol; 2017 Nov; 32(11):1187-1196. PubMed ID: 28116735
[TBL] [Abstract][Full Text] [Related]
8. Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer.
Vera DB; Fredes AN; Garrido MP; Romero C
Life (Basel); 2021 Dec; 12(1):. PubMed ID: 35054401
[TBL] [Abstract][Full Text] [Related]
9. Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.
Retamales-Ortega R; Oróstica L; Vera C; Cuevas P; Hernández A; Hurtado I; Vega M; Romero C
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245631
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor stimulates cellular proliferation of human epithelial ovarian cancer.
Urzua U; Tapia V; Geraldo MP; Selman A; Vega M; Romero C
Horm Metab Res; 2012 Sep; 44(9):656-61. PubMed ID: 22411587
[TBL] [Abstract][Full Text] [Related]
11. Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells.
Garrido MP; Vera C; Vega M; Quest AFG; Romero C
Ther Adv Med Oncol; 2018; 10():1758835918770984. PubMed ID: 29774060
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nerve growth factor by anti-inflammatory drugs, a steroid, and a selective cyclooxygenase 2 inhibitor in human intervertebral disc cells stimulated with interleukin-1.
Alimasi W; Sawaji Y; Endo K; Yorifuji M; Suzuki H; Kosaka T; Shishido T; Yamamoto K
Spine (Phila Pa 1976); 2013 Aug; 38(17):1466-72. PubMed ID: 23574818
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of nerve growth factor on thecal cells from antral ovarian follicles.
Dissen GA; Parrott JA; Skinner MK; Hill DF; Costa ME; Ojeda SR
Endocrinology; 2000 Dec; 141(12):4736-50. PubMed ID: 11108289
[TBL] [Abstract][Full Text] [Related]
15. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
Repasky GA; Zhou Y; Morita S; Der CJ
Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.
Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M
Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
18. A role for trkA nerve growth factor receptors in mammalian ovulation.
Dissen GA; Hill DF; Costa ME; Les Dees CW; Lara HE; Ojeda SR
Endocrinology; 1996 Jan; 137(1):198-209. PubMed ID: 8536613
[TBL] [Abstract][Full Text] [Related]
19. GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling.
Parida S; Pal I; Parekh A; Thakur B; Bharti R; Das S; Mandal M
Cell Death Dis; 2016 Mar; 7(3):e2154. PubMed ID: 27010855
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
